olaparib,apalutamide
astrazeneca,merck,janssen
['cspc', 'propel', 'prostate', 'presto']
 prof. de bono comments on #presto and #propel trials in #prostatecancer #esmo22 presto (apa in hr -nmcspc) is a good idea but we need more robust data. 
Medical oncologist in training at @HospitalSantPau ???? ????. Interested in #GUOnco, #rstat and #writing. Opinions=own.